Menu  → Metabolism information on chemical compounds  → 
Ginsenoside Ra3
Ginsenoside Ra3

Compound Ginsenoside Ra3 
Animal species rat 
Metabolism parameters  
Metabolites (20S)-Ginsenoside Ra3
Crude drug Ginseng 
References 1) Houfu Liu, Junling Yang, Feifei Du, Xiumei Gao, Xutao Ma, Yuhong Huang, Fang Xu, Wei Niu, Fengqing Wang, Yu Mao, Yan Sun, Tong Lu, Changxiao Liu, Boli Zhang, and Chuan Li, Absorption and disposition of ginsenosides after oral administration of Panax notoginseng extract to rats. Drug Metabolism and Disposition, 37: 2290–2298 (2009). 
Remarks Ginsenosides were administered to rats, either in the form of Sanqi extract or as pure chemicals. Systemic exposure to ginsenosides Ra3, Rb1, and Rd after oral administration of the extract was significantly greater than that to the other compounds. Considerable colonic deglycosylation of the ginsenosides occurred, but the plasma levels of deglycosylated metabolites were low in rats. Poor membrane permeability and active biliary excretion are the two primary factors limiting systemic exposure to most ginsenosides and their deglycosylated metabolites. [Li et al., Drug Metabolism and Disposition, 37: 2290–2298 (2009)] 
 

TOPICS

Information on genetic analysis

Information of bioassay

Metabolism information on chemical compounds included in crude drugs

Traditional Medical & Pharmaceutical Database


Section of Pharmacognosy,
Division of Medicinal Resources,
Department of Research and Development,
Institute of Natural Medicine,
University of Toyama
2630 Sugitani, Toyama 930-0194 Japan
TEL: +81-76-434-7601
FAX: +81-76-434-5064